Nephrology

Your Article Summary

See Latest Articles

Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients
Néphrologie & Thérapeutique , 06/09/09

Montagnac R et al. - Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, the authors evoke these complications and illustrate them with some pictures from personal observations.

Today in Dialysis...keeping you current

Receive free subspecialty "5-minute updates" via email

Managing diabetes in hemodialysis patients: Observations and recommendations
Cleveland Clinic Journal of Medicine, 11/04/09

Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
JAMA, 10/29/09

Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey
Nephrology Dialysis Transplantation, 10/30/09

See All of Dialysis

Today in Fluids and Electrolytes...keeping you current

Receive free subspecialty "5-minute updates" via email

Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09

New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children
Pediatric Nephrology, 11/11/09

Does Concomitant Administration of Sevelamer and Calcium Carbonate Modify the Control of Phosphatemia
Therapeutic Apheresis and Dialysis, 11/04/09

See All of Fluids and Electrolytes